OpenLegislation

Regulation 214A Amendment of regulation 294 (general requirements)F1I1

In regulation 294, after paragraph (4) insert—

“(5)

In the case of an advertisement which relates to a medicinal product for sale or supply—

(a)

in Northern Ireland only, the requirements of this regulation must be met in relation to the product for sale or supply in Northern Ireland,

(b)

in Great Britain only, the requirements of this regulation must be met in relation to the product for sale or supply in Great Britain, and

(c)

in the whole of the United Kingdom, the requirements of this regulation must be met in relation to both—

(i)

the product for sale or supply in Great Britain, and

(ii)

the product for sale or supply in Northern Ireland.”.

Annotations

Textual amendments

F1

Reg. 214A inserted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 172

Commencement

I1

Reg. 214A in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1